1st Quarter - Report

PREMIER, INC. for PREMIER, INC.

Period 1st Quarter 2018 Filed Apr 20, 2018 Signed by Blair Childs

Official filing
Firm
PREMIER, INC.
Client
PREMIER, INC.
Income
—
Expenses
$630,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FAST Genetics Act of 2017 (H.R. 2051) CREATES Act of 2017 (H.R. 2212/S. 974) Preserve Access to Affordable Generics Act (S. 124) 340B PAUSE ACT (H.R. 4710) Legislation to place a moratorium on the 340B drug payment cuts in the CY 2018 Outpatient Prospective Payment System Rule (H.R. 4392) Protecting Jessica Grubbs Legacy Act (S. 1850) Overdose Prevention and Patient Safety Act (H.R. 3545) ACA Medicaid disproportionate share hospital (DSH) cuts Childrens Health Insurance Program (CHIP) funding ACO Improvement Act of 2017 (H.R. 4580) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109)

LobbyistCovered position, as disclosed
BLAIR GORDON CHILDS —
DUANNE PEARSON —
MARGARET REAGAN —
SHARA SIEGEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4710 (115th), S. 1738 (115th), H.R. 592 (115th), H.R. 1316 (115th), H.R. 2212 (115th), S. 124 (115th), H.R. 3178 (115th), H.R. 2051 (115th), H.R. 4580 (115th), S. 109 (115th), S. 1044 (115th), S. 1850 (115th), H.R. 1939 (115th), H.R. 3545 (115th), H.R. 1038 (115th), S. 413 (115th), S. 974 (115th), H.R. 4392 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.